Effectiveness of a combined exercise training and home-based walking programme on physical activity compared with standard medical care in moderate COPD: a randomised controlled trial.
Study Goal
The researchers aimed to evaluate the effectiveness of a 10-week combined exercise training and home-based walking program on daily physical activity in patients with moderate COPD compared to standard medical care.
Results Summary
The intervention significantly increased daily physical activity by 26.1 minutes/day and improved functional capacity by 34.0 meters compared to the control group, with clinically relevant outcomes.
Population
Patients with stable COPD at Gold Stage II and a score of two or more on the Medical Research Council Dyspnoea Scale (mean age 70.2 years, 34 females).
Effective Dosage
Not specified (home-based walking program combined with exercise training).
Duration
10 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
combined exercise training and home-based walking programme | increase | daily physical activity | patients with moderate chronic obstructive pulmonary disease | 26.1 minutes/day | increased significantly | #1 |
combined exercise training and home-based walking programme | increase | functional capacity | patients with moderate chronic obstructive pulmonary disease | 34.0 m | clinically relevant increase | #2 |
combined exercise training and home-based walking programme | increase | physical activity | patients with moderate COPD | - | improved | #3 |
OBJECTIVE: To estimate the effectiveness of a 10-week combined exercise training and home-based walking programme on daily physical activity (PA) compared with standard medical care in patients with moderate chronic obstructive pulmonary disease (COPD). DESIGN: Randomised controlled trial. SETTING: Primary care physiotherapy. PARTICIPANTS: Consecutive patients with stable COPD at Gold Stage II with a score of two or more on the Medical Research Council Dyspnoea Scale. INTERVENTION: Ten-week combined exercise training and home-based walking programme compared with standard medical care. MAIN OUTCOMES: At baseline and after 10 weeks, daily PA was evaluated by accelerometry using three levels of intensity and expressed as metabolic equivalent of task. In addition, daily activities (Physical Activity Scale for the Elderly), functional exercise capacity (6-minute Walk Test), health-related quality of life (Chronic Respiratory Questionnaire) and exercise self-efficacy (Exercise Self-Regulatory Efficacy Scale) were measured. RESULTS: Fifty-two patients {34 females; mean age 70.2 [standard deviation (SD) 9.5] years; mean forced expiratory volume in 1second 67% (SD 9.2) of predicted} were randomised. PA, adjusted for baseline differences, increased significantly in the intervention group compared with the control group, by 26.1minutes/day [95% confidence interval (CI) 7.3 to 44.9]. The increase in functional capacity between groups was clinically relevant (34.0m, 95% CI 2.3 to 65.6) in favour of the intervention group. CONCLUSIONS: A combined exercise training and home-based walking programme in primary care physiotherapy improved PA in patients with moderate COPD. Clinical trial registration number NL24766.018.08.